CSIMarket Company Name, Ticker, Industry, else..


Mesa Laboratories Inc  (NASDAQ: MLAB)
Other Ticker:  
 
    Sector • Technology    Industry • IT Infrastructure
   Industry • IT Infrastructure
   Sector • Technology

Mesa Laboratories Inc

MLAB's Fundamental analysis



Looking into Mesa Laboratories Inc growth rates, revenue grew by 17.51 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 502

IT Infrastructure industry recorded growth of revenues by 14.59 %

Mesa Laboratories Inc faced net loss in contrast to the net income a year ago in III. Quarter 2024

• More on MLAB's Growth


Mesa Laboratories Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 229.56 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.66.
IT Infrastructure industry's Price to Sales ratio is at 3.42.


• More on MLAB's Valuation
 
 Total Debt (Millions $) 124
 Dividend TTM ($) 0.64 $
 Dividend Yield TTM (%) 0.55 %
 Revenue/Employee (TTM) $ 320,043
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 6.14
 Tangible Book Value (Per Share $) -22.13

Mesa Laboratories Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 229.56 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.66.
IT Infrastructure industry's Price to Sales ratio is at 3.42.

Mesa Laboratories Inc Price to Book Ratio is at 4.04 lower than Industry Avg. of 311.44. and higher than S&P 500 Avg. of 0.01

• More on MLAB's Valuation

•  Market Capitalization (Millions $) 627
•  Shares Outstanding (Millions) 5
•  Employees 736
•  Revenues (TTM) (Millions $) 236
•  Net Income (TTM) (Millions $) -249
•  Cash Flow (TTM) (Millions $) 3
•  Capital Exp. (TTM) (Millions $) -4
•  Total Debt (Millions $) 124
•  Dividend TTM ($) 0.64 $
•  Dividend Yield TTM (%) 0.55 %
•  Revenue/Employee (TTM) $ 320,043
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 6.14
•  Tangible Book Value (Per Share $) -22.13

•  Market Capitalization (Millions $) 627
•  Shares Outstanding (Millions) 5
•  Employees 736
•  Revenues (TTM) (Millions $) 236
•  Net Income (TTM) (Millions $) -249
•  Cash Flow (TTM) (Millions $) 3
•  Capital Exp. (TTM) (Millions $) -4


    MLAB's Profitability Comparisons
Mesa Laboratories Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2024 to 9.21 % from 6.11 % in II. Quarter.




Profitability by Segment
Sterilization and Disinfection Control 70.03 %
Clinical Genomics 54.85 %
Biopharmaceutical Development 61.61 %
Calibration Solutions 61.03 %



  Ratio
•   Capital Ratio (MRQ) 0.71
•  Total Debt to Equity (MRQ) 0.8
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.53
•  Inventory Turnover Ratio (TTM) 2.83



Mesa Laboratories Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2024 to 9.21 % from 6.11 % in II. Quarter.



• More on MLAB's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com